World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
11661
World Ranking
15539
National Ranking
6481

Overview

Youli Zu is affiliated with Houston Methodist in the United States and has a research focus spanning the fields of medicine and biochemistry, genetics, and molecular biology. Their scholarly output includes numerous contributions to molecular biology, pathology and forensic medicine, oncology, genetics, and hematology.

Their research addresses several specialized topics, including:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Advanced biosensing and bioanalysis techniques
  • CAR-T cell therapy research
  • Acute Myeloid Leukemia Research
  • Cancer Genomics and Diagnostics
  • RNA Interference and Gene Delivery

They have published in various scientific venues, with frequent appearances in:

  • UNC Libraries
  • Blood
  • Nature Communications
  • Journal of Hematology & Oncology
  • Journal for ImmunoTherapy of Cancer

Recent papers by Youli Zu include:

  • Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection, 2021, Angewandte Chemie International Edition
  • MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma, 2022, Nature Communications
  • MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma, 2020, Blood
  • XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53, 2020, Journal of Hematology & Oncology
  • Oligonucleotide aptamers for pathogen detection and infectious disease control, 2021, Theranostics

The scientist has collaborated frequently with several coauthors, notably:

  • Alexandar Tzankov
  • Govind Bhagat
  • Zijun Y. Xu-Monette
  • April Chiu
  • Eric D. Hsi

Best Publications

  • Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

    Hongguang Sun;Xun Zhu;Patrick Y Lu;Roberto R Rosato

  • MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

    Shimin Hu;Zijun Y. Xu-Monette;Alexander Tzankov;Tina Green

  • Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

    Catherine M. Bollard;Catherine M. Bollard;Stephen Gottschalk;Stephen Gottschalk;Vicky Torrano;Vicky Torrano;Oumar Diouf;Oumar Diouf

  • Detecting Circulating Tumor Cells: Current Challenges and New Trends

    Bin Hong;Youli Zu

  • p38 Mitogen-Activated Protein Kinase Activation Is Required for Human Neutrophil Function Triggered by TNF-α or FMLP Stimulation

    You Li Zu;Jiafan Qi;Annette Gilchrist;Gustavo A. Fernandez

  • Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

    Zijun Y. Xu-Monette;Lin Wu;Carlo Visco;Yu Chuan Tai

  • A Highlight of recent advances in aptamer technology and its application

    Hongguang Sun;Youli Zu

  • Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts.

    Nilanjana Maulik;Masazumi Watanabe;You Li Zu;Chi Kuang Huang

  • Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study

    C Visco;Y Li;Z Y Xu-Monette;R N Miranda

  • Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2

    Nilanjana Maulik;Tetsuya Yoshida;You Li Zu;Motoaki Sato

  • Multiplexed volumetric bar-chart chip for point-of-care diagnostics

    Yujun Song;Yuanqing Zhang;Paul E. Bernard;James M. Reuben

  • CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

    Shimin Hu;Zijun Y. Xu-Monette;Aarthi Balasubramanyam;Ganiraju C. Manyam

  • Aptamers and their applications in nanomedicine.

    Hongguang Sun;Youli Zu

  • Human T cell L-plastin bundles actin filaments in a calcium-dependent manner.

    Yuziro Namba;Masaya Ito;Youli Zu;Katsuya Shigesada

  • Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

    Catherine M. Bollard;Catherine M. Bollard;Catherine M. Bollard;Tamara Tripic;Conrad Russell Cruz;Gianpietro Dotti;Gianpietro Dotti

  • Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

    Chi Young Ok;Ling Li;Zijun Y. Xu-Monette;Carlo Visco

  • Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

    Carlo Visco;Alexander Tzankov;Zijun Y. Xu-Monette;Roberto N. Miranda

  • Aptamers: versatile molecular recognition probes for cancer detection

    Hongguang Sun;Weihong Tan;Youli Zu

  • Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

    Qing Ye;Zijun Y Xu-Monette;Alexandar Tzankov;Lijuan Deng

  • Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the international DLBCL rituximab-CHOP consortium program study (Leukemia (2014) 28 (980) Doi:10.1038/leu.2014.24)

    C. Visco;Y. Li;Z. Y. Xu-Monette;R. N. Miranda

Frequent Co-Authors

Govind Bhagat
Govind Bhagat Columbia University
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Santiago Montes-Moreno
Santiago Montes-Moreno Instituto de Investigación Marqués de Valdecilla
Yong Li
Yong Li Baylor College of Medicine
Ching-Hsuan Tung
Ching-Hsuan Tung Cornell University
Xiaobo Zhou
Xiaobo Zhou The University of Texas Health Science Center at Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring studies in Biology and Biochemistry opens the door to a diverse range of online degrees and rewarding career options. For those looking to quickly enter a health-related field, programs like the accelerated nutrition degree online provide a flexible and fast-track opportunity to graduation and immediate workforce entry.

If you’re seeking a blend of science and business, consider the cheapest online mba in healthcare management. This degree can help advance your career in hospital administration, pharmaceutical management, or public health leadership, all while staying budget-friendly.

Several graduates transition to fields like medical coding and health information management. Pursuing ccs certification (Certified Coding Specialist) is a pathway that sets you apart for specialized coding roles in clinical settings. Understanding the differences in certification can help you choose the best route for career growth.

Curious about compensation in this fast-growing sector? Learn more about what is medical coding salary and the steps to enter this field with your background in biology and biochemistry.

Best Scientists Citing Youli Zu

Trending Scientists

Recently Published Articles